TechLink Facebook Twitter Linkedin Search File Previous Next Arrow Right Materials Sensors Medical Biotechnology Millitary Tech Photonics Communications Electronics Energy Environmental Software Information and Technology Other Technologies Double Arrow Left

Air Force

Bilirubin tests as risk predictors for systemic lupus erythematosus and psoriatic arthritis

  • US Patent No. 6905880
  • Issued: June 14, 2005
  • Status: Expired
Medical & Biotechnology

A new method for predicting the risk of cancer morality, rheumatoid arthritis; systemic lupus erythematosus, psoriatic arthritis, and all-cause mortality is disclosed. The method uses serum bilirubin levels as indicator for such risks, lower serum bilirubin levels generally indicating increased risk and higher levels a decreased risk.

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us